Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaleb Michaud

Showing results (251-260 of 273) with videos related to

Pageof 28
Sort By:
Pharmacoepidemiology and Drug Safety|August 26, 2015
Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approachFredrik Nyberg, Johan Askling, Niklas Berglind, et al.
Arthritis Care & Research|July 24, 2015
Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational RegistriesSuzanne M M Verstappen, Johan Askling, Niklas Berglind, et al.
Rheumatology (Oxford, England)|September 29, 2017
Enrichment of malondialdehyde-acetaldehyde antibody in the rheumatoid arthritis jointTed R Mikuls, Michael J Duryee, Rafid Rahman, et al.
Annals of Internal Medicine|September 27, 2021
The Safety and Immunologic Effectiveness of the Live Varicella-Zoster Vaccine in Patients Receiving Tumor Necrosis Factor Inhibitor Therapy : A Randomized Controlled TrialJeffrey R Curtis, Stacey S Cofield, S Louis Bridges, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2016
Associations of Circulating Cytokines and Chemokines With Cancer Mortality in Men With Rheumatoid ArthritisBryant R England, Jeremy Sokolove, William H Robinson, et al.
Annals of the Rheumatic Diseases|December 2, 2015
How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registriesJohan Askling, Niklas Berglind, Stefan Franzen, et al.
Annals of the Rheumatic Diseases|February 10, 2016
Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular diseaseKaleb Michaud, Niklas Berglind, Stefan Franzén, et al.
RMD Open|October 31, 2017
Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programmeHisashi Yamanaka, Johan Askling, Niklas Berglind, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 20, 2022
2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee ArthroplastySusan M Goodman, Bryan D Springer, Antonia F Chen, et al.
Pain Medicine (Malden, Mass.)|August 13, 2011
Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address themM Cary Reid, David A Bennett, Wen G Chen, et al.
Pageof 28

Showing results (251-260 of 273) with videos related to

Sort By:
Pageof 28
Pharmacoepidemiology and Drug Safety|August 26, 2015
Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approachFredrik Nyberg, Johan Askling, Niklas Berglind, et al.
Arthritis Care & Research|July 24, 2015
Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational RegistriesSuzanne M M Verstappen, Johan Askling, Niklas Berglind, et al.
Rheumatology (Oxford, England)|September 29, 2017
Enrichment of malondialdehyde-acetaldehyde antibody in the rheumatoid arthritis jointTed R Mikuls, Michael J Duryee, Rafid Rahman, et al.
Annals of Internal Medicine|September 27, 2021
The Safety and Immunologic Effectiveness of the Live Varicella-Zoster Vaccine in Patients Receiving Tumor Necrosis Factor Inhibitor Therapy : A Randomized Controlled TrialJeffrey R Curtis, Stacey S Cofield, S Louis Bridges, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2016
Associations of Circulating Cytokines and Chemokines With Cancer Mortality in Men With Rheumatoid ArthritisBryant R England, Jeremy Sokolove, William H Robinson, et al.
Annals of the Rheumatic Diseases|December 2, 2015
How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registriesJohan Askling, Niklas Berglind, Stefan Franzen, et al.
Annals of the Rheumatic Diseases|February 10, 2016
Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular diseaseKaleb Michaud, Niklas Berglind, Stefan Franzén, et al.
RMD Open|October 31, 2017
Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programmeHisashi Yamanaka, Johan Askling, Niklas Berglind, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 20, 2022
2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee ArthroplastySusan M Goodman, Bryan D Springer, Antonia F Chen, et al.
Pain Medicine (Malden, Mass.)|August 13, 2011
Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address themM Cary Reid, David A Bennett, Wen G Chen, et al.
Pageof 28